Moderna Inc. (MRNA) is expected to report second-quarter earnings this Thursday. Prices for the stock of the vaccine maker have been strong, but the latest candlestick pattern and movement in the indicators tell us to be cautious. Let's check.
More from Stocks
The S&P 500 and DJIA are convenient benchmarks, but they can hurt your returns if you give them too much weight.
Here's what I found most positive about the market as the week closed out.
I like to identify a chart or two with a nice setup into the next week, and OB falls into that category.